Cellectar Biosciences adopts 2021 Stock Incentive Plan
Cellectar Biosciences, Inc. filed an exhibit adopting the 2021 Stock Incentive Plan. The document outlines terms for granting stock awards to officers, employees, and service providers to align their interests with those of stockholders.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day